Association between normal-weight obesity and cardiometabolic risk factors among adults in Addis Ababa, Ethiopia

DOI: https://doi.org/10.21203/rs.3.rs-2479785/v1

Abstract

Background: The relationship between normal-weight obesity (NWO) – high percent body fat (%BF) in individuals with normal body mass index (BMI) – and cardiometabolic abnormalities has not been explored in Africa. We determined the prevalence of NWO and evaluated its association with hypertension, elevated blood sugar and dyslipidaemia among adults in Addis Ababa, Ethiopia.

Methods: A cross-sectional study was conducted among adults 18-64 years (n=600). Blood pressure, blood glucose, lipid profile, and anthropometric measurements were completed. As function of skinfold thickness, body density and %BF were estimated using Durnin & Womersley and Siri Equations, respectively. The relationship between NWO and the outcomes of interest, assessed using adjusted linear and logit models.

Results: The age- and sex-standardised prevalence of NWO was 18.9% (95% confidence interval (CI): 15.8, 22.2%). Comparison between normal-weight lean (normal %BF and BMI) and normal-weight obese individuals suggested no difference in systolic blood pressure (β=2.55; 95% CI, -0.82, 5.92); however, diastolic blood pressure (β=3.77: 95% CI, 1.37, 6.18) and odds of hypertension (adjusted odds ratio (AOR)=2.46: 95% CI, 1.18, 5.13) were significantly raised in the latter. Similarly, adults with NWO had elevated blood glucose (β=2.30; 95% CI, 1.23, 15.66) and increased odds of high blood sugar level (AOR=1.68; 95% CI, 1.05, 2.67). LDL (β = 8.73: 1.56, 15.90), triglyceride (β=20.99: 0.78, 41.22), total cholesterol (β=10.47: 1.44, 19.50), and Cholesterol to HDL ratio (β=0.65: 0.27, 1.04) were also raised among adults with NWO.

Conclusion: NWO is common among adults in Addis Ababa and is associated with cardiometabolic derangements.

Background

Non-communicable diseases (NCDs) annually cause 41 million deaths, equivalent to more than two-third of all global deaths 1. Low- and middle-income countries (LMIC) disproportionally take more than three-fourth of NCD-related deaths 1,2. Four clinical conditions – cardiovascular diseases, cancers, chronic respiratory disease and diabetes mellitus – alone contribute to 80% of all NCD-related deaths 1. Globally between 2000 and 2019, the total adult mortality attributable to NCDs has increased by 31% 3.

Overweight including obesity, defined as accumulation of excessive or abnormal fat, is an established risk factor for hypertension, insulin resistance, dyslipidemia and several types of cancers 1,4,5. Annually nearly 4 million people die as the consequence of high body mass index (BMI) 6. In the last three decades the global prevalence of overweight including obesity has increased from 29 to 38% and obesity-related deaths and disability-adjusted life years (DALYs) have doubled 69. In Ethiopia 3.1% of men and 7.6% of women are either overweight or obese 10.

BMI is the most frequently used metric for classifying overweight and obesity. However, BMI does not differentiate fat mass from lean mass, causing misclassification of individuals with high adiposity as normal 11,12. Recently normal-weight obesity (NWO) – a condition characterized by excess fat in individuals with normal BMI – is receiving increasing attention 1214. It has been reported that the “invisible obesity” is common and is linked with multiple cardiometabolic disfunctions 1519. Though there is no universally agreed threshold for excess percent body fat (%BF) 12,20, studies from in India 15 and China 16 came across with high rates of NWO. Normal-weight obese, as compared to normal-weight lean individuals, have higher risks of metabolic syndrome and dying from cardiovascular conditions 17,18,21.

Studies have suggested that the patterns of obesity and obesity-related comorbidities considerably vary across different populations 2224. However, to the best of our knowledge, the epidemiology and cardiometabolic consequences of NWO have not been investigated in African population before. In this study we determined the prevalence of NWO and explored its association with hypertension, elevated blood sugar and dyslipidaemia among adults in Addis Ababa, Ethiopia.

Methods

Study design and setting

We used data from the baseline survey of the SuNCD-AA (Surveillance of Non-Communicable Diseases in Addis Ababa) project designed to monitor the epidemiology of chronic diseases in the city on a five-yearly basis using the WHO’s STEPwise Approach to NCD Risk Factor Surveillance (STEPS) 25. The SuNCD-AA baseline survey was completed in June 2021.

Addis Ababa, is the capital and largest city of Ethiopia and has an estimated population of 4.5 million, of which 68% are adults 18–64 years of age 26. Administratively Addis Ababa is divided into 10 sub-cities and 116 districts and has 12 public hospitals, 40 private hospitals, 96 health centres and more than 800 clinics. In 2006, a STEPS survey in the city reported high prevalence of overweight and obesity (29%), low physical activity (25%) and hypertension (30%) among adults 25–64 years of age 27.

Study population and design

In the SuNCD-AA survey, women and men 18 to 64 years of age, who were permanent residents of the city were eligible for inclusion irrespective of their medical history. Women participants were excluded if they had a self-reported pregnancy or gave birth in the preceding 12 months of the survey.

The baseline survey enrolled 600 adults 18–64 years of age. The original sample size was estimated using Cochran's single population proportion formula 28 assuming 95% confidence level, 4% margin of error, 21% expected prevalence of overweight and obesity and design effect (DEFF) of 1.5. DEFF of 1.5 was determined using the standard DEFF = 1 + δ (n – 1) formula taking cluster size (n) of 20 and intra-cluster correlation of (δ) of 2%. Post-hoc analysis indicated, the available sample size was adequate to estimate 18.9% prevalence of NWO with 95% confidence level, 4% margin of error and DEFF of 1.5.

Study subjects were selected using multistage cluster sampling approach. Initially from each of the 10 sub-cities 1 district, and subsequently from each district 2 villages (“ketena”), were drawn using lottery method. Ultimately 20 villages were represented in the study. In each of villages, using urban health extension workers’ database as a sampling frame, 20 households were selected at random. In each of selected household eligible subjects were listed and one was selected using simple random sampling technique. Few selected individuals who were not willing to take part in the study or could not be found at home after repeated visits had been replaced with randomly selected eligible subjects from adjacent households.

Variables of the study

The explanatory variable, NWO, was defined as having normal BMI (18.5–24.9 kg/m²) with high %BF. As there is no universally agreed excess body fat threshold 12,20, we primarily used the age- and sex-specific cut-offs (≤ 20th percentile of the norms) proposed by American College of Sports Medicine (ACSM) for adults 20 years or older 29. The ACSM thresholds that we used were: > 23.1 to28.4% for men and > 27.1 to 35.4% for women, according to age 29. As the ACSM provided no thresholds for adolescents 18 or 19 years of age, we applied the norms for young adults (20–29 years) to this group.

We have also provided alternative NWO prevalence figures based on the following three sex-specific %BF thresholds commonly used in the literature: (1) American Council on Exercise (ACE) threshold (≥ 25% for men and ≥ 32% for women) 30, (2) ≥ 25% for males and ≥ 35% for females 31 and (3) ≥ 20·6% for men and ≥ 33·4% for women 15,32.

The primary outcomes of interest were blood pressure, blood glucose level and lipid profile (low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride and total cholesterol). The primary outcomes were analysed both as continuous and dichotomous variables. We considered age and sex as key control variables.

Based on JNC 7 classification 33, hypertension was defined as a systolic blood pressure (SBP) of 140 mm Hg or more, or a diastolic blood pressure (DBP) of 90 mm Hg or above, or currently on medication for raised blood pressure. Base on the recommendation of American Diabetic Association, we defined elevated blood sugar by aggregating prediabetic (Fasting Blood Sugar (FBS) between 100 and125 mg/dl or Postprandial Blood Sugar (PPBS) between 140 ann199 mg/dl) and diabetic (FBS > = 126 mg/dl or PPBS > = 200 mg/dl or on medication for raised blood sugar) states 34. Elevated LDL (≥ 100 mg/dL), triglyceride (≥ 150 mg/dL) and total cholesterol (≥ 200 mg/dL), and low HDL (< 40 mg/dL) were defined using clinically relevant cut-off values. Total cholesterol to HDL ratio was calculated as composite index of dyslipidaemia.

Data collection tools and procedures

Data were collected following the STEPwise Approach, a standardized method for monitoring behavioural, dietary and metabolic risk factors of NCDs 25. The STEPS questionnaire was translated to Amharic language, pretested and contextualized to the local setting. Questions extracted from the standard Demographic and Health Survey (DHS) questionnaire were used to collect socio-demographic information. Physical activity level was measured using the Global Physical Activity Questionnaire (GPAQ) incorporated into the STEPS tool and classified as high, moderate or low based on the level of metabolic equivalent of task (MET)-minutes per week 25.

Data were digitally collected using the Open Data Kit (ODK)® system via KoBo Toolbox® platform. Enumerators and supervisors were trained nurses with extensive field experience. The training included standardization of anthropometric measurements and procedures for measuring blood pressure and blood sugar levels.

Anthropometric measurements

All participants underwent weight, height, waist and hip circumferences and skinfold measurements in the field following standard procedures. Weight was measured to the nearest 100 g without shoes and heavy clothing using SH2003B® digital scale (accuracy ± 100 g). Standing height was measured without shoes to the nearest 0.1 cm using portable Heuer® stadiometer. BMI was calculated as weight in kilograms divided by height in meters squared and classified as underweight (< 18.5), normal (18.5–24.9), overweight (25.0–29.9) or obese ( > = 30).

Waist and hip circumferences were measured to the nearest 0.1 cm using a non-stretchable flexible tape with minimal clothing. Waist circumference was classified as normal (men < 94 cm and women < 80 cm), increased risk (men 94–102 cm and women 80–88 cm) or greatly increased risk (men > 102 cm and women > 88 cm) 35. Waist-to-hip ratio (WHR) was classified as normal (men < 0.90 and women < 0.85) or substantially increased (men ≥ 0.90 and women ≥ 0.85) 35.

All anthropometric measurements were performed in duplicate and if the difference was within a tolerable range (200 g for weight, 0.5 cm for height, and 1 cm for waist and hip circumferences), the average was used. Otherwise, the measurements were repeated.

Skinfold measurement and estimation of gross body composition

Dual-energy X-ray absorptiometry (DXA) is considered as the gold standard for measuring body fat. However, its applicability in community-based studies of low-income countries is limited to due to cost and feasibility reasons. In this study, we estimated body fat using the validated Durnin & Womersley Equation based on four skinfold measurements 36.

Triceps, biceps, subscapular and suprailiac skinfold thicknesses measurements were completed in duplicate to the nearest millimetre using Plicometro® callipers. Body density (g/ml) was predicted based on Durnin & Womersley Equation as a function of four skinfold measurements 36. Though multiple equations have been proposed to estimate %BF using skinfold measurements, the Durnin & Womersley Equation has showed the strongest concordance with DXA measurements 37. According to the equation, \(\text{B}\text{o}\text{d}\text{y} \text{d}\text{e}\text{n}\text{s}\text{i}\text{t}\text{y}\left(\frac{\text{g}}{\text{m}\text{l}}\right)=x-\left(y\text{log}10L\right)\)where: L is the total of the skinfolds (mm) and x and y are age- and sex- specific constants. Then %BF was determined using the Siri Eq. 38, \(\text{\%} \text{B}\text{F}=(495/\text{D}) – 450\), where D is density of the body (g/ml) estimated using Durnin & Womersley Equation. Ultimately fat body mass (FBM) was computed by multiplying total bodyweight by %BF and lean body mass (LBM) was determined by subtracting FBM from the total bodyweight.

Lipid profile, blood pressure and blood sugar measurements

Blood pressure was measured using Folee® automated digital monitor system in sitting position after 15 minutes of rest. In individuals with recent exercise, smoking, heavy meal or caffeine intake, the measurement was delayed for at least 30 minutes. The measurement was repeated twice and if the difference was within acceptable limit (10 mmHg in SBP and 5mmHg in DBP) the average was recorded. Otherwise, a new set of readings was taken. Random blood glucose level was determined from capillary blood using Diavue® monitoring system. Lipid panel including, including low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride and total cholesterol were determined at the national reference laboratory of Ethiopian Public Health Institute (EPHI).

Statistical analysis

SPSS version 25 was used for data processing and analysis. Survey weights were applied to adjust for differences in probability of selection and to align the sample with known age and sex profile of the population. Survey weights were determined as a product of design weight and poststratification weight. Design weight was computed as inverse of the sampling fraction. Poststratification weight was determined based on the age and sex composition of the city as reported in the recent national census 26.

Categorical variables are expressed using frequency distributions. The normality of numeric variables was first assessed using Kolmogorov-Smirnov test and then appropriate measures of central tendency and dispersion were used to summarize the data. Arithmetic mean (± standard deviation (SD)) and median (inter-quartile range (IQR)) were applied for normal and skewed distributions, respectively. For proportions, 95% confidence interval (CI) was estimated using STATA’s binomial CI calculator. We also used a series of Pearson’s chi-square and chi-square tests for trend tests to compare proportions across two or more levels.

The association between NWO and the outcomes of interest was measured by comparing normal-weight lean (normal %BF and BMI) and normal-weight obese individuals. Simple and multiple linear regression models were fitted for continuous outcomes (SBP, DBP and blood sugar level) and unstandardized regression coefficients (β) were used for interpretation. For dichotomous outcomes (hypertension, elevated blood glucose level, low HDL and elevated LDL, triglycerides and cholesterol) bivariable and multivariable logistic regression models were fitted and crude (COR) and adjusted (AOR) odds ratio were reported. All multivariable models were adjusted for age and sex.

Ethical considerations

The protocol was cleared by Institutional Review Board of College of Health Sciences, Addis Ababa University (109/20/SPH). Data were collected after taking informed written consent from the study participants. The study was performed in accordance with the national and international ethical guidelines.

Results

Basic characteristics

Data were obtained from 600 adults 18–64 years of age. With male to female ratio of 0.93, women were slightly over represented. The mean (± SD) age of the participants was 31.2 (± 11.4) years and more than two-third were younger than 40 years. The vast majority (93%) had formal education, nearly half (46.8%) were married and more than two-thirds were employed at the time of the survey. The median (IQR) monthly household income was 4,000 (2500–7000) Ethiopian Birr (equivalent to95 (59–167) USD) and the median household size was 4 (3–5) (Table 1).

Table 1

Socio-demographic characteristics of the survey participants, Addis Ababa, Ethiopia, June 2021.

Socio-demographic characteristics (n = 600)

Frequency

Percentage

Sex

   

Men

290

48.3

Women

310

51.7

Age (years)

   

18–24

214

35.6

25–39

256

42.6

40–54

97

16.2

55–64

33

5.5

Educational status

   

No formal schooling

42

7.0

Primary education

169

28.2

Secondary education

249

41.5

Higher education

140

23.3

Marital status

   

Married/Cohabiting

281

46.8

Not ever married

269

44.8

Widowed

20

3.3

Divorced/separated

31

5.1

Occupation

   

Not working (including retired)

182

30.4

Trade (including petty trade)

107

17.9

Student

102

17.0

Professional/technical/managerial

91

15.1

Manual (skilled or unskilled)

78

13.0

Others

39

6.6

Religion

   

Orthodox Christian

486

81.1

Muslim

92

15.3

Protestants

19

3.1

Others

4

0.6

Anthropometry and gross body composition

The mean (± SD) BMI was 24.1 (± 4.4) kg/m² and 38.7% of the adults were either overweight or obese (BMI ≥ 25.0). The mean waist circumference was 81.8 (± 13.9) cm in men and 80.7 (± 13.9) cm in women; whereas, the mean waist-to-hip ratio was 0.89 (± 0.12) and 0.83 (± 0.12) in the two genders, respectively. Based on waist circumference, nearly one in three adults had increased or greatly increased risk and based on waist-to-hip ratio index, 40.9% had substantially increased risk (Table 2).

Table 2

Anthropometric profile of adults 18–64 years in Addis Ababa, Ethiopia, June 2021.

Anthropometric profile

Men (n = 290)

Women (n = 310)

Both (n = 600)

Freq

%

Freq

%

Freq

%

Body mass index (kg/m²)

           

Underweight (< 18.5)

34

11.6

8

2.6

42

7.0

Normal (18.5–24.9)

163

56.3

163

52.6

326

54.4

Overweight (25.0–29.9)

76

26.4

102

32.7

178

29.7

Obese ( > = 30)

17

5.7

37

12.1

54

9.0

Waist circumference

           

Normal

236

81.6

157

50.5

393

65.5

Increased risk

35

12.2

72

23.2

107

17.9

Greatly increased risk

18

6.3

82

26.3

100

16.6

Waist to hip ratio (cm)

           

Normal

175

60.6

179

57.7

354

59.1

Substantially increased

114

39.4

131

42.3

246

40.9

The mean predicted density of the body based on Durnin & Womersley Equation was 1,038 (± 17) kg/m3 and the average %BF was 27.0%. The estimated prevalence of obesity based on %BF was 51.8% (30.5% in men and 71.8% in women). Fat mass (kg) and %BF were higher in women and fat free mass (kg) was higher in men (Table 3).

Table 3

Gross body composition among adults 18–64 years in Addis Ababa, Ethiopia, June 2021.

Gross body composition indices

Men (n = 290)

Women (n = 310)

Both (n = 600)

Mean (± SD) predicted body density (kg/m3)

1,049 (± 13)

1,027 (± 12)

1,038 (± 17)

Mean (± SD) percent body fat (%)

21.8 (± 6.2)

31.9 (± 5.9)

27.0 (± 7.8)

Mean (± SD) fat mass (kg)

14.3 (± 6.3)

18.8 (± 6.5)

16.6 (± 6.8)

Mean (± SD) fat free mass (kg)

49.2 (± 7.7)

38.8 (± 5.9)

43.8 (± 8.6)

Body weight (kg)

63.5 (12.5)

57.5 (11.1)

60.4 (12.2)

Obesity estimated based on %BF

30.5

71.8

51.8

Prevalence of normal-weight obesity

Based on the %BF thresholds recommended by ACSM (> 23.1–28.4% in men and > 27.1–35.4 in women, according to age), the age- and sex-standardized prevalence of NWO among adults in Addis Ababa was 18.9% (95% CI: 15.8–22.2%). Among adults with normal BMI, 34.8% (95% CI: 30.0–40.1%) had NWO (Fig. 1).

Figure 2 depicts the prevalence of NWO as per four different %BF thresholds commonly used in the literature. The use of the ACSM age- and sex-specific limits provided the highest prevalence of 18.9%. Conversely, %BF threshold of ≥ 25% for men and ≥ 35% for women yielded the lowest prevalence of 8.8%. The choice %BF threshold differentially affects the sex-specific prevalence of NWO as well (Fig. 2).

We assessed the pattern or NWO (defined using the ACSM threshold) status across levels of sex, age and physical activity. NWO prevalence varied considerably between women (27.0%) and men (10.3%) (p = 0.0144), but did not significantly differ across age categories, 20.0% and 15.3%, among adults 18–39 and 40–64 years, respectively (p = 0.113). Regarding physical activity, the prevalence of NWO decreased from 28.4% in adults with low physical activity to 17.6% and 15.3% among those with moderate and high physical activities levels, respectively (p = 0.001).

Association between normal-weight obesity and blood pressure, blood glucose and lipid profile

Multiple linear regression analysis detected no significant difference in SBP (β = 2.55; 95% CI, -0.82, 5.92) between normal-weight lean and normal weight obese adults. However, DBP was significantly raised in the latter (β = 3.77; 95% CI, 1.37, 6.18). Multivariable logit model adjusted for age and sex also indicated that adults with NWO had nearly twofold increased odds of hypertension (AOR = 2.46; 95% CI, 1.18, 5.13).

Similarly, adults with NWO had significantly higher blood glucose concentration (β = 2.30; 95% CI, 1.23, 15.66) and increased odds of elevated glucose level (AOR = 1.68, 95% CI, 1.05–2.67) (Table 4).

Table 4

Association of normal-weight obesity with blood pressure, dyslipidaemia and blood sugar levels among adults 18–64 years, Addis Ababa, Ethiopia

Continuous outcomes: Mean (± SD)

Normal-weight obesity

Normal-weight lean

Linear regression (β with 95% confidence interval)

Crude

Adjusted§

Systolic blood pressure (mmHg)

116.8 (± 16.1)

115.8 (± 14.1)

1.05 (-2.34, 4.44)

2.55 (-0.82, 5.92)

Diastolic blood pressure (mmHg)

79.3 (± 11.4)

75.9 (± 9.8)

3.45 (1.08, 5.82)*

3.77 (1.37, 6.18)*

Blood sugar level (mg/dl)

115.1 (± 32.7)

106.4 (± 27.8)

8.62 (1.86, 15.38)*

7.28 (0.70, 13.87)*

Low-density lipoprotein (LDL) (mg/dL)

94.1 (± 31.2)

84.9 (± 28.1)

9.19 (2.49, 15.89)*

8.73 (1.56, 15.90)*

High-density lipoprotein (HDL) (mg/dL)

42.9 (± 13.0)

44.5 (± 11.3)

-1.60 (-4.32, 1.13)

-2.76 (-5.61, 0,10)

Triglyceride (mg/dl)

143.2 (± 102.5)

138.8 (± 78.3)

4.43 (-15.60, 24.46)

20.99 (0.78, 41.22)*

Total cholesterol (mg/dl)

160.6 (± 41.6)

151.0 (± 34.7)

9.60 (1.08–18.13)*

10.47 (1.44–19.50)*

Cholesterol to HDL

4.08 (± 2.37)

3.57 (± 1.15)

0.51 (0.13, 0.90)*

0.65 (0.27, 1.04)*

Categorical outcomes (%)

Normal-weight obesity

Normal-weight lean

Logistic regression (odds ratio with 95% confidence interval)

Crude

Adjusted§

Hypertension (%)

19.5

11.3

1.95 (1.04, 3.67)*

2.46 (1.18, 5.13)*

Elevated blood sugar level (%)

23.9

12.7

2.18 (1.21–3.95)*

2.03 (1.11–3.73)*

Elevated LDL (≥ 100 mg/dL) (%)

37.2

19.2

2.48 (1.49, 4.14)*

2.52 (1.42, 4.47)*

Low HDL (< 40 mg/dL) (%)

61.9

64.3

1.13 (0.70, 1.81)

1.24 (0.73, 2.11)*

Elevated triglyceride (≥ 150 mg/dL) (%)

32.7

30.5

1.12 (0.69–1.83)

2.08 (1.14–3.78)*

Elevated cholesterol (≥ 200 mg/dL) (%)

12.4

7.0

1.87 (0.87–4.04)

2.72 (1.17–6.32)*

* Statistically significant association at P value of 0.05

Codded as:0 = normal weight obesity absent, 1 = normal weight obesity present

§ Adjusted for age and sex

Includes prediabetic and diabetic blood sugar levels

We also compared the lipid profile between adults with and without NWO. Multiple linear regression model adjusted for age and sex detected no statistically significant difference in HDL concertation (β = -2.76: -5.61, 0,10). However, LDL (β = 8.73: 1.56, 15.90), triglyceride (β = 20.99: 0.78, 41.22) and total cholesterol (β = 10.47: 1.44–19.50) were all significantly raised among adults with NWO. The odds of elevated LDL (AOR = 2.52: 1.42, 4.47), triglyceride (AOR = 2.08: 1.14–3.78) and cholesterol (AOR = 2.72: 1.17–6.32) were all raised among adults with NWO than their counterparts.

Cholesterol to HDL ratio among adults with NWO (4.08 ± 2.37) was also significantly lower in adults with normal BMI but raised %BF (3.57 ± 1.15), (β = 0.65: 0.27, 1.04) (Table 4).

Discussion

We examined the prevalence of NWO and its association with cardiometabolic risk factors. We found NWO is fairly common in adults from Addis Ababa and more frequently occurs among women and adults with low physical activity levels. Our study suggested significant association between NWO and hypertension, dyslipidaemia and elevated sugar level.

After applying age- and sex- specific %BF thresholds (> 23.1–28.4% in men and > 27.1–35.4 in women, according to age) we found that nearly one-in-five adults in Addis Ababa had NWO. In South Korea 32 and India 15, based on sex-specific thresholds (≥ 20·6% for men, ≥ 33·4% for women), 32% prevalence of NWO was reported. In Colombia, using sex-specific cut-offs (> 25.5% for men, > 38.9% for women) 29% of adults 18–30 years had NWO 39. It is important to note that the prevalence figures reported across the studies cannot be directly compared due to differences in %BF thresholds applied to define excess adiposity. Yet, the studies suggested that NWO is common in many countries including LMIC.

The high prevalence of NWO that we observed among adults in Addis Ababa suggested that in clinical and research contexts, assessment of cardiometabolic risk factors solely based on BMI may lead to considerable misinterpretation of adiposity. Routine assessment of body fat enables researchers and practitioners to differentiate normal-weight adults with and without excess adiposity.

We observed considerable differences in the crude and sex-specific prevalence of NWO as defined based on four adiposity thresholds. In Switzerland the prevalence of NWO varied noticeably according to the cut-off used to define %BF 20. Reviews conducted on the topic have also documented the same 12,31. The finding implies that there is an obvious need for developing optimized excess adiposity thresholds for different populations.

According to the results, a sizable difference in the prevalence of NWO was observed between men (10.3%) and women (27.0%). Though women are known to have more body fat than men, the natural difference should have been offset by the use of sex-specific thresholds. In this regard, the available studies have so far reported conflicting findings 17,32,39. In Colombia the prevalence in women (46%) was substantially higher than in men (2.0%) 39; but the opposite was true among Korean adults (36 and 29% in men and women, respectively) 32. On the other hand, the magnitude was fairly balanced between Brazilian men (9.2%) and women (9.0%) 17. The higher prevalence of NWO that we observed in women can be either due to elevated true risk in women (e.g., low physical activity) or inadequate optimization the %BF thresholds to counterbalance the natural adiposity difference between the two genders.

We observed an inverse association between NWO and levels of physical activity. The finding is consistent to the understanding that greater physical activity results in lower adiposity irrespective of BMI 40,41. A secondary analysis of the UK Biobank Assessment Centres data concluded that physical activity was inversely associated with adiposity even among people with the same BMI 40. In China similar pattern of association was also observed among older adults (40–64 years) with BMI below 24 kg/m2 41. The finding implies that, on top of the proven benefit for optimizing BMI, physical activity can reduce adiposity among adults with normal BMI.

Our study showed NWO was associated with significantly increased odds of hypertension (OR = 2.5) and raised blood sugar level (OR = 1.7). Reports from US 18,42, Asian 15,16,19 and Latin American 17,39 populations have indicated that increase in adiposity within normal BMI range raises the risk of insulin resistance and/or hypertension. According to a study from India, NWO increased risk of diabetes but not hypertension 15. In US the association with hypertension was only limited to men 18.

We found that NWO was associated higher cholesterol to HDL ratio and increased odds of elevated LDL (AOR = 2.5), triglyceride (AOR = 2.1) and cholesterol (AOR = 2.7). However, it was not associated with HDL level. In Korean 32 and Indian 15 adults, NWO has been also associated with atherogenic lipid profile. A cohort study in Brazil found that low HDL and high triglyceride were common among Brazilian young adults 17. A study among Colombian young adults (18 to 30 years) reported that prevalence of high LDL was 29% and 21% in NWO and NWL adults respectively, but the difference did not reach statistically significant levels 39. Low HDL level was more common among adults with NWO 39.

Uniqueness of this study is that it assessed the epidemiology of NWO in African setting where no study has been done on the topic so far; furthermore, it assessed the association of NWO with multiple outcomes including elevated blood sugar, hypertension and dyslipidaemia. Yet, the study is not without limitations. First, the ACSM thresholds applied to define excess adiposity had not been validated in the setting and this may have caused an over- or under-estimation of NWO. Second, we estimated %BF using a validated equation as a function of multiple skinfold measurements; however, this method is not accurate as DXA or bioelectrical impedance methods. Third, with the intension of maximizing our sample size, individuals who have not consented to study or could not be found at home were replaced with others from the neighbourhood. This may have introduced selection bias in the study. Finally, while assessing the association between NWO and blood sugar level, we aggregated prediabetes and diabetes states together because the number of diabetic cases were too small for meaningful analysis. This may have introduced a misclassification bias in the study.

Conclusion

Normal-weight obesity is common in adults from Addis Ababa and more frequently affects women and adults with low physical activity level. In the population that we studied, NWO is associated with increased risk of hypertension, hyperlipidaemia and elevated sugar level. The study implies, screening of cardiometabolic risk factors solely based on BMI may lead to considerable underestimation of adiposity and its consequences.

Abbreviations

%BF                Percent body fat

AOR                Adjusted odds ratio

ACE                American Council on Exercise

ACSM             American College of Sports Medicine

BMI                Body mass index

COR                Crude odds ratio 

CI                    Confidence interval 

DALYs           Disability-adjusted life years

DBP                Diastolic blood pressure

DEFF              Design effect 

DHS                Demographic and Health Survey

DXA               Dual-energy X-ray absorptiometry

EPHI               Ethiopian Public Health Institute

FBS                 Fasting blood sugar 

GPAQ             Global Physical Activity Questionnaire

IQR                 Inter-quartile range 

HDL                High-density lipoprotein 

LDL                Low-density lipoprotein

LMIC              Low- and middle-income countries

MET                Metabolic equivalent of task 

NCDs              Non-communicable diseases

NWO              Normal-weight obesity 

ODK               Open Data Kit

PPBS               Postprandial Blood Sugar

SBP                 Systolic blood pressure 

SD                   Standard deviation 

STEPS             STEPwise Approach to NCD Risk Factor Surveillance

SuNCD-AA    Surveillance of Non-Communicable Diseases in Addis Ababa

WHR               Waist-to-hip ratio 

Declarations

Ethics approval and consent to participate

The protocol was cleared by Institutional Review Board of College of Health Sciences, Addis Ababa University (109/20/SPH). Data were collected after taking informed written consent from the study participants. The study was performed in accordance with the national and international ethical guidelines. 

Consent for publication

NA. The manuscript does not contain any individual person’s data in any form.

Availability of data and materials

The datasets used during the current study are available from the corresponding author on reasonable request.

Competing interests

The authors declare no conflict of interest. 

Funding

The study was funded by the Thematic Research Program of Addis Ababa University, Ethiopia. 

Author’s Contributions 

SG:  conceptualization, methodology, software, validation, formal analysis, investigation, data curation, writing - original draft, writing - review & editing, visualization, supervision, project administration, funding acquisition

MM: investigation, writing - review & editing

SH: conceptualization, methodology, writing - review & editing, funding acquisition

KB: conceptualization, methodology, writing - review & editing, funding acquisition

BS: conceptualization, methodology, writing - review & editing, funding acquisition

AB: conceptualization, methodology, writing - review & editing, funding acquisition

TB: conceptualization, methodology, writing - review & editing, funding acquisition

Acknowledgement 

The authors acknowledge all study participants who took part in the study. 

References

  1. WHO. Noncommunicable diseases: key facts. 2021. Accessed from https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases on Aug 10, 2021.
  2. Ezzati M, Pearson-Stuttard J, Bennett JE, Mathers CD. Acting on non-communicable diseases in low- and middle-income tropical countries. Nature 2018; 559: 507–516. Doi: 0.1038/s41586-018-0306-9.
  3. WHO. Global Health Estimates 2020: Deaths by cause, age, sex, by country and by region, 2000–2019. Geneva: WHO; 2020.
  4. WHO. Diet, nutrition and the prevention of chronic diseases: Report of the joint WHO/FAO expert consultation. Geneva: WHO; 2003.
  5. Kivimäki M, Kuosma E, Ferrie JE, Luukkonen R, Nyberg ST, Alfredsson L et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health 2017; 2(6): e277-e285. Doi: 10.1016/S2468-2667(17)30074-9.
  6. GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. The New England Journal Medicine 2017; 377(1): 13–27. Doi: 10.1056/NEJMoa1614362.
  7. NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 2016; 387: 1377–96. Doi: 10.1016/S0140-6736(16)30054-X.
  8. The GBD 2013 Obesity Collaboration. Global, regional and national prevalence of overweight and obesity in children and adults 1980–2013: A systematic analysis. Lancet 2014; 384(9945): 766–781. Doi: 10.1016/S0140-6736(14)60460-8.
  9. Dai H, Alsalhe TA, Chalghaf N, Matteo Riccò M, Bragazzi NL, Wu J. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990–2017: An analysis of the Global Burden of Disease Study. PLoS Medicine 2020; 17(7): e1003198. Doi: 10.1371/journal.pmed.1003198.
  10. Central Statistical Agency of Ethiopia and The DHS Program. Ethiopia: Demographic and Health Survey 2016. Addis Ababa: CSA; Rockville: ICF; 2017.
  11. Liu P, Ma F, Lou H. The utility of fat mass index vs. body mass index and percentage of body fat in the screening of metabolic syndrome. BMC Public Health 2013; 13: 629. Doi: 10.1186/1471-2458-13-629.
  12. Franco LP, Morais CC, Cominetti C. Normal-weight obesity syndrome: diagnosis, prevalence, and clinical implications. Nutrition Reviews 2016; 74(9): 558–570. Doi: 10.1093/nutrit/nuw019.
  13. Wijayatunga NN, Dhurandhar EJ. Normal weight obesity and unaddressed cardiometabolic health risk-a narrative review. International Journal of Obesity 2021. Doi: 10.1038/s41366-021-00858-7
  14. Oliveros E, Somers VK, Sochor O, Goel K, Lopez-Jimenez F. The concept of normal weight obesity. Progress in Cardiovascular Diseases 2014; 56 (4): 426–433. Doi: 10.1016/j.pcad.2013.10.003.
  15. Kapoor N, Lotfaliany M, Sathish T, Thankappan KR, Nihal Thomas, Furler J et al. Prevalence of normal weight obesity and its associated cardio-metabolic risk factors - Results from the baseline data of the Kerala Diabetes Prevention Program (KDPP). PLoS One 2020; 15(8): e0237974. Doi: 10.1371/journal.pone.0237974.
  16. Zheng Q, Lin W, Liu C, Zhou Y, Chen T, Zhang L, et al. Prevalence and epidemiological determinants of metabolically obese but normal-weight in Chinese population. BMC Public Health 2020; 20: 487. Doi: 10.1186/s12889-020-08630-8.
  17. Madeira FB, Silva AA, Veloso HF, Goldani MZ, Kac G, Cardoso VC et al. Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country. PLoS One 2013; 8(3): e60673. Doi: 10.1371/journal.pone.0060673.
  18. Romero-Corral A, Somers VK, Sierra-Johnson J, Korenfeld Y, Boarin S, Korinek J. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. European Heart Journal 2010; 31(6): 737–46. Doi: 10.1093/eurheartj/ehp487.
  19. Xu S, Ming J, Aihua Jia, Xinwen Yu, Cai J, Jing C. Normal weight obesity and the risk of diabetes in Chinese people: a 9-year population-based cohort study. Scientific Reports 2021;11(1): 6090. Doi: 10.1038/s41598-021-85573-z.
  20. Marques-Vidal P, Chiolero A, Paccaud F. Large differences in the prevalence of normal weight obesity using various cut-offs for excess body fat. European e-Journal of Clinical Nutrition and Metabolism 2008; 3: e159ee162. Doi: 10.1016/j.eclnm.2008.05.003.
  21. Jimenez-Mora MA, Nieves-Barreto LD, Montaño-Rodríguez A, Betancourt-Villamizar EC, Mendivil1 CO. Association of overweight, obesity and abdominal obesity with socioeconomic status and educational level in Colombia. Diabetes Metabolic Syndrome and Obesity: Targets and Therapy. 2020; 13: 1887–1898. Doi: 10.2147/DMSO.S244761.
  22. Cossrow N, Falkner B. Race/ethnic issues in obesity and obesity-related comorbidities. The Journal of Clinical Endocrinology & Metabolism 2004; 89(6): 2590–2594. Doi: 10.1210/jc.2004-0339.
  23. Heymsfield SB, Peterson CM, Thomas DM,Heo M,Schuna JM Jr. Why are there race/ethnic differences in adult body mass index–adiposity relationships? A quantitative critical review. Obesity Review 2016; 17(3): 262–275. Doi: 10.1111/obr.12358.
  24. Luo1 J, Hendryx M, Laddu D, Phillips LS, Chlebowski R, LeBlanc ES. Racial and ethnic differences in anthropometric measures as risk factors for diabetes. Diabetes Care 2019; 42(1): 126–133. Doi: 10.2337/dc18-1413.
  25. WHO. STEPwise Approach to NCD Risk Factor Surveillance (STEPS). Accessed from https://www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/steps on August 11, 2021.
  26. Population Census Commission Ethiopia. Summary and statistical reports of the 2007 population and housing census: Population size by age and sex. Addis Ababa: CSA; 2008.
  27. Tesfaye F, Byass P, Wall S. Population based prevalence of high blood pressure among adults in Addis Ababa: uncovering a silent epidemic. BMC Cardiovascular Disorders 2009; 9: 39. Doi:10.1186/1471-2261-9-39.
  28. Cochran WG. Sampling techniques (3rd ed.). New York: John Wiley & Sons; 1977.
  29. American College of Sport Medicine. ACSM's health-related physical fitness assessment manual (3rd ed.). Baltimore: Lippincott & Wilkins; 2010.
  30. American Council on Exercise (ACE). Anthropometric Measurements: When to Use this Assessment. Accessed from: https://www.acefitness.org/ on 18 August, 2021.
  31. Ho-Pham LT, Campbell LV, Nguyen TV. More on body fat cutoff points. Mayo Clin Proc 2011; 86(6): 584–5. Doi: 10.4065/mcp.2011.0097.
  32. Kim MK, Han K, Kwon H, Song K, Yim HW, Lee W, Park Y. Normal weight obesity in Korean adults. Clin Endocrinol (Oxf) 2014; 80(2): 214–20. Doi: 10.1111/cen.12162.
  33. National Institutes of Health. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. NIH; 2004.
  34. American Diabetes Association. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care 2021; 44(Suppl 1): S15–S33. Doi: 10.2337/dc21-S002.
  35. WHO. Waist circumference and waist-Hip ratio: Report of a WHO Expert Consultation. GENEVA: WHO; 2008.
  36. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. British Journal of Nutrition 1974; 32(1):77–97. Doi: 10.1079/bjn19740060.
  37. Bacchi E, Cavedon V, Zancanaro C, Moghetti P, Milanese C. Comparison between dual-energy X-ray absorptiometry and skinfold thickness in assessing body fat in overweigh/obese adult patients with type-2 diabetes. Scientific Report 2017; 7(1): 17424. Doi: 10.1038/s41598-017-17788-y.
  38. Siri WE. Body composition from fluid space and density. In J. Brozek & A. Hanschel (Eds.). Techniques for measuring body composition. Washington, DC: National Academy of Science; 1961.
  39. Correa-Rodríguez M, González-Ruíz K, Rincón-Pabón D, Izquierdo M, García-Hermoso A, Agostinis-Sobrinho C, et al. Normal-weight obesity is associated with increased cardiometabolic risk in young adults. Nutrients 2020; 12(4): 1106. Doi: 10.3390/nu12041106
  40. Bradbury KE, Guo W, Cairns BJ, Armstrong MEG, Key TJ. Association between physical activity and body fat percentage, with adjustment for BMI: A large cross-sectional analysis of UK Biobank. BMJ Open 2017; 7(3):e011843. Doi: 10.1136/bmjopen-2016-011843.
  41. Zou O, Su C, Du W, Ouyang Y, Wang H, Wang Z, et al. The association between physical activity and body fat percentage with adjustment for body mass index among middle-aged adults: China health and nutrition survey in 2015. BMC Public Health 2020; 20: 732. Doi: 10.1186/s12889-020-08832-0.
  42. Martinez KE, Tucker LA, Bailey BW, LeCheminant JD. Expanded normal weight obesity and insulin resistance in US adults of the National Health and Nutrition Examination Survey. Journal of Diabetes Research 2017: 9502643. Doi: 10.1155/2017/9502643.